WE-REACH

November 23, 2020

Dr. Ho Talks Pfizer and COVID-19 Vaccine Distribution with KOMO News 4

KOMO News 4

Dr. Rodney Ho, Executive Director of WE-REACH, discussed the Pfizer COVID-19 vaccine and the challenges of distributing a treatment that requires -80 degree Celsius freezer storage with KOMO News last Friday. While “it is logistically challenging,” Dr. Ho believes that “we have prepared the best as we can.” For the full story, follow the link…


November 13, 2020

WE-REACH Funds Two COVID-19 Rapid Diagnostics Projects as Part of Expanded Initiatives

Drs. Chung and Lutz

Seattle, WA (November 13, 2020)—The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is pleased to announce two awards to develop rapid point-of-care diagnostic tests for COVID-19. By securing about $500k in additional funding from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), WE-REACH is investing in the development of rapid, portable COVID-19 testing…


August 24, 2020

NEW Fast track funding for developing COVID-19 biosensors for skin or oral cavities | Preapplications DUE September 9, 2020

WE-REACH is announcing fast track funding for early-stage projects aimed at developing biosensors for COVID-19 open to researchers in the Pacific Northwest. This one-time opportunity through the NIH is part of the Emergency RADx-Rad initiative to detect the virus or other biomarkers in nasal and oral cavities or skin. This funding is intended to support…


August 12, 2020

Current Call for WE-REACH Proposals

On August 21st, Declarations of Intent (DOIs) are due for WE-REACH Project Funding and Support. The call is open for projects led by University of Washington PIs or collaborators with UW Co-PIs. The intent is to assist investigators in completing proof of product concept validation and securing follow-on funding. For more information, see our request…


July 14, 2020

Biomedical Innovations Win WE-REACH Go-To-Market Awards

Seattle, WA (July 14, 2020)—The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is pleased to announce its first awards to facilitate early-stage product development for two biomedical innovations. WE-REACH invests up to $200,000 per awarded project. Funding comes from the NIH with matching support from our partners at the Institute of Translational Health Sciences,…


July 13, 2020

Engineering Innovations in Health (EIH) Call for Submissions

Engineering Innovations in Health (EIH), a collaborator with WE-REACH, is opening up a call for submssions for its yearlong program to develop working, cost-effective solutions to health challenges that are positioned to make a clinical impact in a wide range of specializations. Applications, due on August 1st can be found at the following link. For additional…


May 18, 2020

Entrepreneurial Law Clinic Virtual Office Hours

The Entrepreneurial Law Clinic (ELC) at the University of Washington (a WE-REACH collaborator) is now offering a series of Virtual Office Hours in partnership with the Seattle Public Library to discuss the impact of COVID-19 on business and commercialization. The ELC’s resources are as follows: UW Entrepreneurial Law Clinic COVID-19 Virtual Office Hours – Corporate…


May 14, 2020

WE-REACH Welcomes Teddy Johnson

Photo of Teddy Johnson

We are pleased to welcome Teddy Johnson, P.E., MBA, to the WE-REACH team! Teddy brings 25+ years of medical product development and commercialization experience to his role as Associate Director, Technology Development which is a split role with the Institute of Translational Health Sciences (ITHS). Teddy will work closely with investigators who are taking their early stage…


Federal and State Technology (FAST) Partnership

The U.S. Small Business Administration (SBA) announces the 2020 Federal and State Technology (FAST) Partnership Program.  FAST provides one-year funding to organizations to execute state or regional programs that increase the number of SBIR/STTR proposals leading to an increase in the number of SBIR/STTR awards. SB-OIIFT-20-001 Federal and State Technology (FAST) Partnership Program Prospective applicants are encouraged…


April 29, 2020

NIBIB Announces Rapid Acceleration of Diagnostics (RADx) Program

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the NIH Point-of-Care…


Next page